Applied Molecular Transport Stock Current Valuation
| AMTIDelisted Stock | USD 0.33 0.00 0.00% |
Valuation analysis of Applied Molecular helps investors to measure Applied Molecular's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Applied Molecular's price fluctuation is very steady at this time. Calculation of the real value of Applied Molecular is based on 3 months time horizon. Increasing Applied Molecular's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Applied Molecular is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Applied Stock. However, Applied Molecular's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.33 | Real 0.27 | Hype 0.33 | Naive 0.34 |
The intrinsic value of Applied Molecular's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Applied Molecular's stock price.
Estimating the potential upside or downside of Applied Molecular Transport helps investors to forecast how Applied stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Applied Molecular more accurately as focusing exclusively on Applied Molecular's fundamentals will not take into account other important factors: Applied Molecular Transport Company Current Valuation Analysis
Applied Molecular's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Applied Molecular Current Valuation | (5.88 M) |
Most of Applied Molecular's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Molecular Transport is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Applied Molecular Transport has a Current Valuation of (5.88 Million). This is 100.04% lower than that of the Biotechnology sector and 100.13% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.04% higher than that of the company.
Applied Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Applied Molecular's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Applied Molecular could also be used in its relative valuation, which is a method of valuing Applied Molecular by comparing valuation metrics of similar companies.Applied Molecular is currently under evaluation in current valuation category among its peers.
Applied Fundamentals
| Return On Equity | -1.58 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (5.88 M) | |||
| Shares Outstanding | 41.85 M | |||
| Shares Owned By Insiders | 21.35 % | |||
| Shares Owned By Institutions | 37.20 % | |||
| Number Of Shares Shorted | 292.87 K | |||
| Price To Book | 0.70 X | |||
| Gross Profit | (42.08 M) | |||
| EBITDA | (127.22 M) | |||
| Net Income | (126.33 M) | |||
| Cash And Equivalents | 95.83 M | |||
| Cash Per Share | 2.46 X | |||
| Total Debt | 36.12 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 6.25 X | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (93.9 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (1.89) X | |||
| Price To Earnings To Growth | (0.01) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 13 | |||
| Beta | 2.29 | |||
| Market Capitalization | 11.01 M | |||
| Total Asset | 107.45 M | |||
| Retained Earnings | (365.97 M) | |||
| Working Capital | 48.93 M | |||
| Z Score | -7.95 | |||
| Net Asset | 107.45 M |
About Applied Molecular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Applied Molecular Transport's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied Molecular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied Molecular Transport based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |